- cafead   Oct 13, 2023 at 12:12: PM
via BioNTech on Thursday entered into a strategic research collaboration and worldwide licensing agreement with Suzhou-based biotech MediLink Therapeutics to develop next-generation antibody-drug conjugates for cancer.
article source
article source